The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Women’s Health

LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
Editor's Choice

LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis

MAY 1, 2026
Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure
Clinical & Manufacturing

Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure

APR 16, 2026
Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
Editor's Choice

Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment

APR 8, 2026
Women’s Health Innovation Is Not Failing – The System Around It Is
Finance

Women’s Health Innovation Is Not Failing – The System Around It Is

MAR 31, 2026
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
Clinical & Manufacturing

Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence

MAR 24, 2026
Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way
Basic & Discovery Research

Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way

FEB 5, 2026
The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
Editor's Choice

The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies

NOV 12, 2025
Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome
Pharma & Human Health

Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome

FEB 12, 2025
Changes in microbiome predict risk for sexually transmitted disease
Basic & Discovery Research

Changes in microbiome predict risk for sexually transmitted disease

JAN 22, 2025
Freya Biosciences Announces $10.4 Million Strategic Investment from the Bill & Melinda Gates Foundation
Finance

Freya Biosciences Announces $10.4 Million Strategic Investment from the Bill & Melinda Gates Foundation

NOV 19, 2024
A potential non-invasive stool test and novel therapy for endometriosis
Basic & Discovery Research

A potential non-invasive stool test and novel therapy for endometriosis

OCT 16, 2024